Antithrombotic therapy - Summary of recommendations and evidence
UFH can be used routinely.	I	A
LMWH can be used routinely.	I	A
Subcutaneous fondaparinux 2.5 mg can be used once/day for 8 days or until hospital discharge.	I	B
For patients using fondaparinux, administer UFH 85 lU/kg intravenously at the time of PCI, or 60 lU/kg for those receiving GP llb/llla inhibitors.	I	B
Enoxaparin is preferential to UFH unless myocardial revascularization surgery is planned within 24 h.	IIa	A
Consider discontinuing anticoagulation after PCI unless there is an indication to maintain it.	IIa	C
Heparin cross-over (UFH and enoxaparin).	III	B